Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys

Science

Volumn 312, Issue 5779, 2006, Pages 1530-1533

  Letvin, Norman L ^a,b   Mascola, John R ^a   Sun, Yue ^b   Gorgone, Darci A ^b   Buzby, Adam P ^b   Xu, Ling ^a   Yang, Zhi Yong ^a   Chakrabarti, Bimal ^a   Rao, Srinivas S ^a   Schmitz, Jörn E ^b   Montefiori, David C ^c   Barker, Brianne R ^b   Bookstein, Fred L ^d,e   Nabel, Gary J ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; DNA; GENETIC ENGINEERING; IMMUNIZATION; PROTEINS; VACCINES; VIRUSES;

ADENOVIRAL VECTORS; AIDS; CELLULAR IMMUNITY CONTROLS; SIMIAN IMMUNODEFICIENCY VIRUS (SIV);

ANIMAL CELL CULTURE;

ADENOVIRUS VECTOR; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; PLASMID DNA; SIMIAN IMMUNODEFICIENCY VIRUS PROTEIN; SIMIAN IMMUNODEFICIENCY VIRUS VACCINE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CELL ORGANELLE; IMMUNE RESPONSE; PRIMATE; VACCINATION; VIRAL DISEASE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CD4+ T LYMPHOCYTE; CELL SURVIVAL; CELLULAR IMMUNITY; DRUG EFFICACY; IMMUNE RESPONSE; MEMORY T LYMPHOCYTE; MONKEY; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; SURVIVAL; VACCINATION; VIREMIA; VIRUS REPLICATION;

AMINO ACID SEQUENCE; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; HUMANS; IMMUNOLOGIC MEMORY; MACACA MULATTA; MOLECULAR SEQUENCE DATA; PLASMIDS; SAIDS VACCINES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; SURVIVAL ANALYSIS; VACCINES, DNA; VACCINES, SYNTHETIC; VIRUS REPLICATION;

SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 33744990609     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1124226     Document Type: Article

References (24)

1. N. L. Letvin, Annu. Rev. Med. 56, 213 (2005).
2. J. W. Mellors et al., Science 272, 1167 (1996).
3. D. H. Barouch et al., Science 290, 486 (2000).
4. R. R. Amara et al., Science 292, 69 (2001).
5. J. W. Shiver et al., Nature 415, 331 (2002).
6. Y. Nishimura et al., Proc. Natl. Acad. Sci. U.S.A. 101, 12324 (2004).
7. I. Ourmanov et al., J. Virol. 74, 2740 (2000).
8. P. Polacino et al., J. Virol. 73, 618 (1999).
9. P. S. Polacino et al., J. Virol. 73, 8201 (1999).
10. J. D. Lifson et al., J. Virol. 71, 9508 (1997).
11. D. R. Casimiro et al., J. Virol. 79, 15547 (2005).
12. T. U. Vogel et al., J. Virol. 77, 13348 (2003).
13. N. L. Letvin et al., J. Virol. 78, 7490 (2004).
14. S. Santra et al., J. Virol. 79, 6516 (2005).
15. M. S. Seaman et al., J. Virol. 79, 2956 (2005).
16. Materials and methods are available as supporting material on Science Online.
17. R. Pal et al., J. Virol. 76, 292 (2002).
18. M. S. Seaman et al., J. Virol. 79, 4580 (2005).
19. Y. Sun et al., J. Immunol. 174, 4753 (2005).
20. J. J. Mattapallil et al., Nature 434, 1093 (2005).
21. R. S. Veazey et al., J. Virol. 74, 57 (2000).
22. P. B. Gilbert et al., J. Infect. Dis. 192, 974 (2005).
23. T. Hulgan et al., J. Infect. Dis. 192, 950 (2005).
24. This work was supported in part with funds from the intramural research program of the Vaccine Research Center, NIAID, NIH.